24 / 30
Modelos predictivos de riesgo
•
Khorana score
•
CATS Vienna score (P-selectin + D-dimer)
•
PROTECH score (chemotherapy: cisplatin, carboplatin & gemcitabine)
•
CONKO score (performance status)
•
New models
•
COMPASS-CAT study
•
ONKO-VTE model
•
Pabinger model (ISTH 2017): D-dimer & tumor site
•
ONCOTHROMB study (BJC 2018 in press): genomic profile